Successful therapy with danazol in refractory autoimmune thrombocytopenia associated with rheumatic diseases

British Journal of Rheumatology

Volumn 36, Issue 10, 1997, Pages 1095-1099

  Blanco, R ^a   Martinez Taboada, V M ^b   Rodriguez Valverde, V ^b   Sanchez Andrade, A ^a   Gonzalez Gay, M A ^a  

^a HOSPITAL XERAL CALDE   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Autoimmune thrombocytopenia; Danazol; Primary antiphospholipid syndrome; Rheumatoid arthritis; Systemic lupus erythematosus

Indexed keywords

AMINOTRANSFERASE; CORTICOSTEROID; DANAZOL; PREDNISONE;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; WEIGHT GAIN;

EID: 0030669192     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.10.1095     Document Type: Article

References (22)

1. Wallace DJ, Dubois EL. In: Wallace DJ, Dubois EL, eds. Dubois lupus erythematosus, 3rd edn. Philadelphia: Lea & Febiger, 1987:438-9.
2. Alarcon-Segovia D, Pérez-Vázquez ME, Villa AR, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome. Semin Arthritis Rheum 1992;21:275-86.
3. Harris EN. Annotation: antiphospholipid antibodies. Br J Haematol 1990;74:1-9.
4. Dasgupta B, Grahame R. Treatment with danazol for refractory thrombocytopenia in rheumatoid arthritis. Br J Rheumatol 1989;28:550-2.
5. Kuroki S, Ohta A, Katoh O, Sueko N, Yamada H, Yamaguchi M. Successful treatment of autoimmune thrombocytopenia and rapidly progressive pneumonitis with recurrent pneumothoraces in a patient with rheumatoid arthritis. Br J Rheumatol 1993;32:855-6.
6. Gernsheimer T, Stratton J, Ballen PJ, Slichter SJ. Mechanisms of response to treatment in autoimmune thrombocytopenic purpura. N Engl J Med 1989;320: 974-80.
7. Hall S, McCormick JL, Greipp PR, Michet CJ, McKenna C. Splenectomy does not cure the thrombocytopenia of systemic lupus erythematosus. Ann Intern Med 1985;102:325-8.
8. Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med 1992;326:107-16.
9. Maier WP, Gordon DS, Howard RF et al. Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia. Arthritis Rheum 1990;33:1233-9.
10. Boumpas DT, Barez S, Klippel JH, Balow JE. Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus. Ann Intern Med 1990;112:674-7.
11. Finch SC, Castro O, Cooper M, Covey W, Erichson R, McPhedarn P. Immunosuppressive therapy of chronic idiopathic thrombocytopenia purpura. Am J Med 1974;56:4-12.
12. Lee YJ, Horstman LL, Ahn YS. Danazol for Henoch-Schönlein purpura. Ann Intern Med 1993;118:827.
13. Tomino Y, Sakai H, Hanzawa S, Ohno J, Kitajima T, Sakai O. Clinical effect of danazol in patients with IgA nephropathy. Jpn J Med 1987;26:162-6.
14. Ahn YS, Rocha R, Mylvaganam R, Garcia R, Duncan R, Harrington WJ. Long-term danazol therapy in auto-immune; thrombocytopenia; unmaintained remission and age-dependent response in women. Ann Intern Med 1989;111:723-9.
15. Cervera H, Jara LJ, Pizarro S et al. Danazol for systemic lupus erythematosus with refractory autoimmune thrombocytopenia or Evan's Syndrome. J Rheumatol 1995;22:1867-71.
16. West SG, Johnson SC. Danazol for the treatment of refractory autoimmune thrombocytopenia in systemic lupus erythematosus. Ann Intern Med 1988;108:703-6.
17. Kavanaugh A. Danazol therapy in thrombocytopenia associated with the antiphospholipid antibody syndrome. Ann Intern Med 1994;121:767-8.
18. Arnet FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1990;33:1101-7.
19. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
20. Mylvaganam R, Ahn YS, Garcia RO, Kim CI, Harrington WJ. Immune modulation by danazol in autoimmune thrombocytopenia. Clin Immunol Immunopathol 1987;42:281-6.
21. Mylvaganam R, Ahn YS, Harrington WJ, Kim CI. Very low-dose danazol in idiopathic thrombocytopenic purpura and its role as an immune modulator. Am J Med Sci 1989;298:215-20.
22. Nesher G, Dollberg L, Zimran A, Hershko C. Hepatosplenic peliosis after danazol and glucocorticoids for ITP [Letter]. N Engl J Med 1985;312:242-3.